In vivo mapping of spontaneous mammary tumors in transgenic mice using MRI and ultrasonography
✍ Scribed by Mirco Galiè; Mirko D'Onofrio; Laura Calderan; Elena Nicolato; Augusto Amici; Caterina Crescimanno; Pasquina Marzola; Andrea Sbarbati
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 767 KB
- Volume
- 19
- Category
- Article
- ISSN
- 1053-1807
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Purpose
To compare T1‐ or T2‐weighted magnetic resonance imaging (MRI) and ultrasonography (US) as tools for in vivo mapping of different tissue components in spontaneous tumors of transgenic mice.
Materials and Methods
Human‐like mammary adenocarcinomas from FVB/neuT transgenic mice were analyzed by T2‐weighted and T1‐weighted MRI at 4.7 Tesla and US and then, after excision, were paraffin‐embedded for histologic analysis. The histologic samples were prepared taking care to obtain sections that spatially matched the MRI and US images as precisely as possible.
Results
US can obtain basic information such as the size of developing tumors in experimental animals and can identify necrotic areas. T2‐weighted MRI, especially if compared to T1‐weighted MRI and/or US, allows advanced analysis of morphologic aspects, with high resolution in the differentiation of details of necrotic areas such as coagulation, liquefaction, biphasic splitting of cysts, and fibrotic and lipidic infiltration.
Conclusion
Of the three methods, T2‐weighted MRI provides the most information about the anatomy of tumors. However, when distinctions between the different types of necrosis are not needed, US analysis is to be preferred for its practicality. J. Magn. Reson. Imaging 2004;19:570–579. © 2004 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
The colony-inhibition test has been iised to demonstrate cellular imrriirnity against spontaneous murine mammary tumors, both in autochthonous, manimury tumor virus (MTV)-carrying BALBIcfC3N arid in ininiutiized, MTV-fret, BALBIc mice. Immunity could be demonstrated in nearly all cases against a nia
Female FVB/N HER-2/neu transgenic mice from the age of 2 months were subcutaneously injected with saline, the peptide Epitalon(R) (Ala-Glu-Asp-Gly) or with the peptide Vilon(R) (Lys-Glu) in a single dose of 1 microg/mouse for 5 consecutive days every month. Epitalon treatment reduced the cumulative
## Abstract Our meta‐analysis was aimed at providing a systematic review of the literature regarding the effect of energy restriction on spontaneous mammary tumors in mice and at providing a more precise pooled (summary) estimate of the risk of mammary tumors. A sensitivity analysis was conducted t
Mice carrying the MMTV-cmyc transgene develop mammary tumors at 9 to 12 months of age. Little is known about karyotypic changes in this model of human breast cancer. We have developed and applied molecular cytogenetic techniques to study chromosomal aberrations that occur in these tumors, namely, co